Is today the day, page-210

I have commented on this in the past. The key paragraph is this.

As disclosed in the announcement of 28 September 2018, no differences were noted in the levels of cell‐free virus (plasma viral load) in the blood. This result was expected because of the effectiveness of current ART, which all trial participants were taking. Plasma viral load was rapidly reduced to undetectable levels in all subjects.

The last sentence is completely different to what was shown at the conference where the viral load was detectable and measurable across the entire trial period.

I am also not able to square that the trial was expect to show a difference in viral levels when it was designed (this was the primary objective) with MM statement made after the trial finish that no difference was expected.